title: Use of a low molecular weight preparation of heparin--ORG 10172 (Lomoparan) in the critically ill.
authors.affiliation: Intensive Care Unit, Westmead Hospital, Sydney, New South Wales, Australia.
authors.forename: G
authors.initials: G
authors.lastname: John
authors.forename: Y
authors.initials: Y
authors.lastname: Shehabi
authors.forename: Y
authors.initials: Y
authors.lastname: Mudaliar
mesh_terms: D002809:Chondroitin Sulfates; D016638:Critical Illness; D003871:Dermatan Sulfate; D005112:Extracorporeal Circulation; D005260:Female; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006440:Hemofiltration; D006496:Heparinoids / Q000627:therapeutic use*; D006497:Heparan Sulfate; D006801:Humans; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000517:prevention & control
chemical_list: D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006496:Heparinoids; D006497:Heparan Sulfate; C035838:danaparoid